| # | Drug | Count |
|---|---|---|
| 0 | ENTECAVIR | 5 |
| 1 | ENTECAVIR ANHYDROUS | 5 |
| 2 | OXALIPLATIN | 5 |
| 3 | FLUOROURACIL | 4 |
| 4 | FLUOROURACIL CREAM, 0.5% | 4 |
| 5 | ISONIAZID | 3 |
| 6 | PYRAZINAMIDE | 3 |
| 7 | LINEZOLID | 2 |
| 8 | RIFAMPICIN | 2 |
| 9 | TOPIRAMATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM HYALURONATE | 1 | 0.0012 |
| 1 | BALANCED SALT SOLUTION | 1 | 0.0008 |
| 2 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 3 | ENTECAVIR | 5 | 0.0004 |
| 4 | ETHAMBUTOL HYDROCHLORIDE | 1 | 0.0004 |
| 5 | PYRAZINAMIDE | 3 | 0.0003 |
| 6 | TOBRAMYCIN AND DEXAMETHASONE | 1 | 0.0003 |
| 7 | RIFAMPICIN | 2 | 0.0002 |
| 8 | ISONIAZID | 3 | 0.0002 |
| 9 | AMPHOTERICIN B | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimycobacterial [EPC] | 3 | 0.0001 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 3 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |
| 4 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |
| 5 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 6 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 5 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Aminosalicylate [EPC] | 1 | 0.0000 |